Moreover, the effect of RB1 alterations on the immune microenvironment in SCLC was verified when adding high expression of YAP1 and enriched interferon gamma (IFN-γ), T-cell response, and human leukocyte antigen (HLA)-related genes (59). Here, RB1 is linked to small cell lung carcinoma.